Clinical trials: Hemodialysis-Associated Amyloidosis
Hemodialysis-Associated Amyloidosis, Dialysis Amyloidosis
A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis
This is an open label, cross-over group, single-centre randomised controlled trial comparing Medium Cut Off Dialyser with High Flux Dialyser in patients with end-stage renal disease on chronic haemodialysis.
- Conditions
- Hemodialysis-Associated Amyloidosis, Dialysis Amyloidosis, Quality of Life
- Trial name
- HD-1 (NCT04160351)
- Testing
- Theranova 400, Elisio-19H
- Where
- Malaysia
- Volunteers
- 44 people
- Sponsor
- Selayang Hospital